ABMIUM target intelligence
adrenomedullin
Adrenomedullin (ADM; AM) is produced from the pro-adrenomedullin precursor, which also gives rise to proadrenomedullin N-terminal peptide (PAMP). Human ADM is represented by NCBI Gene 133 and reviewed UniProtKB P35318, with related ABMIUM catalogue reagents for research use.
Read full target overviewABMIUM research catalogue
Loading products for ADM…
Research context & evidence
Target information is kept separate from product-level validation so you can review the biology and the reagent evidence independently.
The ADM gene encodes pro-adrenomedullin, a precursor processed into biologically active peptides including adrenomedullin and PAMP. Curated NCBI and UniProt records describe adrenomedullin as a vasoactive peptide with potent vasodilatory and hypotensive activity and roles in fluid and electrolyte homeostasis; reviewed UniProt identifies signalling through CALCRL-RAMP2 and CALCRL-RAMP3 receptor complexes.
ADM/adrenomedullin is studied in vascular signalling, endothelial biology, fluid and electrolyte homeostasis, peptide-hormone biology and angiogenesis-related research. ABMIUM product selection should be based on the specific species, assay format, sample type, application and validation stated for each reagent rather than inferred from target biology.
Names used across publications, databases and supplier catalogues.
